[Management of adults presenting with a thrombocytosis].
Viallard
J-F
JF
Service de médecine interne, centre de référence des pathologies plaquettaires rares, hôpital Haut-Lévêque, 5, avenue de Magellan, 33604 Pessac, France. jean-francois.viallard@chu-bordeaux.fr
D000328:Adult; D000465:Algorithms; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D010976:Platelet Count; D055728:Primary Myelofibrosis / Q000175:diagnosis* / Q000188:drug therapy*; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors; D013920:Thrombocythemia, Essential / Q000175:diagnosis / Q000188:drug therapy; D013922:Thrombocytosis / Q000175:diagnosis* / Q000188:drug therapy*; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018906:Antineoplastic Agents, Alkylating; D004791:Enzyme Inhibitors
Conduite à tenir devant une thrombocytose.